HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
FCGRT |
FCGRT, FCRN: IgG receptor FcRn large subunit p51 precursor |
79.510 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
79.510 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
FCGRT |
FCGRT, FCRN: IgG receptor FcRn large subunit p51 precursor |
79.510 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
79.510 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
BMX |
IPI00514142 |
79.430 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
79.430 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
79.430 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
79.430 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
78.480 |
Evidence |
O
|
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
78.480 |
Evidence |
|
POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
78.480 |
Evidence |
O
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
78.260 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
78.260 |
Evidence |
O
|
BMX |
IPI00514142 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
78.260 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
HCK |
IPI00029769 |
78.260 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
78.260 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
78.260 |
Evidence |
|
BMX |
IPI00514142 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
78.260 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
78.260 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
78.260 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
78.260 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
78.260 |
Evidence |
|
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
78.260 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
78.260 |
Evidence |
|
BMX |
IPI00514142 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
78.260 |
Evidence |
|